Most recently, it's been identified that conolidine and the above mentioned derivatives act around the atypical chemokine receptor 3 (ACKR3. Expressed in identical areas as classical opioid receptors, it binds to the big selection of endogenous opioids. Not like most opioid receptors, this receptor acts as being a scavenger https://billf531fhj3.wikimillions.com/user